Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Octagon Capital Advisors LP | 855,900 9.100% | 855,900 (New Position) | Filing History |
| 2024-07-18 4:10 pm Purchase | 2024-07-16 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 855,900 9.990% | 855,900 (New Position) | Filing History |
| 2024-02-14 6:41 pm Purchase | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 347,211 9.990% | 142 (+0.04%) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 347,571 9.900% | 226,830 (+187.86%) | Filing History |
| 2024-02-14 3:18 pm Unchanged | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 97,600 2.730% | 0 (Unchanged) | Filing History |
| 2024-02-02 8:32 pm Purchase | 2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 212,175 6.100% | 212,175 (New Position) | Filing History |
| 2024-01-22 4:27 pm Purchase | 2023-06-26 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Logos Global Management LP | 3,469,927 9.900% | 3,469,927 (New Position) | Filing History |
| 2023-07-14 4:30 pm Purchase | 2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 5,996,173 9.990% | 5,996,173 (New Position) | Filing History |
| 2023-07-06 5:23 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | BIOTECHNOLOGY VALUE FUND L P | 347,023 9.990% | 347,023 (New Position) | Filing History |
| 2023-07-06 4:30 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 347,069 9.990% | 347,069 (New Position) | Filing History |
| 2023-02-14 4:52 pm Sale | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 120,742 8.000% | -3,934 (-3.16%) | Filing History |
| 2023-02-14 1:41 pm Purchase | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 97,600 6.080% | 17,600 (+22.00%) | Filing History |
| 2022-02-14 9:37 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 80,000 5.100% | 80,000 (New Position) | Filing History |
| 2022-02-14 08:35 am Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 124,676 8.000% | 124,676 (New Position) | Filing History |
| 2022-02-14 06:11 am Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Altium Capital Management LLC | 17,600 1.200% | 17,600 (New Position) | Filing History |
| 2022-01-20 4:23 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors Inc. | 96,948 6.500% | 15,693 (+19.31%) | Filing History |
| 2021-09-23 4:54 pm Purchase | 2021-09-14 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors Inc. | 81,256 5.600% | 81,256 (New Position) | Filing History |